Share Name Share Symbol Market Type Share ISIN Share Description
Abcam Plc LSE:ABC London Ordinary Share GB00B6774699 ORD 0.2P
  Price Change % Change Share Price Shares Traded Last Trade
  1.00 0.07% 1,532.00 618,559 16:35:12
Bid Price Offer Price High Price Low Price Open Price
1,540.00 1,542.00 1,549.00 1,501.00 1,501.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 260.00 8.40 6.00 255.3 3,473
Last Trade Time Trade Type Trade Size Trade Price Currency
18:45:04 O 587 1,532.077 GBX

Abcam (ABC) Latest News

More Abcam News
Abcam Investors    Abcam Takeover Rumours

Abcam (ABC) Discussions and Chat

Abcam Forums and Chat

Date Time Title Posts
12/1/202118:39ABCAM with Charts & News185
19/11/201720:07Investing ? Start with your ABC's703
29/8/201322:08ABCAM - another e-Commerce Retailer120

Add a New Thread

Abcam (ABC) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Abcam trades in real-time

Abcam (ABC) Top Chat Posts

Abcam Daily Update: Abcam Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker ABC. The last closing price for Abcam was 1,531p.
Abcam Plc has a 4 week average price of 1,499p and a 12 week average price of 1,385p.
The 1 year high share price is 1,739p while the 1 year low share price is currently 943p.
There are currently 226,719,849 shares in issue and the average daily traded volume is 581,693 shares. The market capitalisation of Abcam Plc is £3,473,348,086.68.
cokehookerscars: Can't see why this stock isn't going higher. Held for quite a while before this CoronaVirus but certainly expected a very nice uptick beyond current levels. Ha ha ha !! I just added that exact same link, ifthecapfits. It seems these guys might be hard at work and pulling in some serious revenue. Will be interesting to see if the government beats them down on price a lot though.
bathcoup: Issue of Shares to Durable Capital Partners LP at an issue price of 1,100 pence per share. 09/04/2020 5:33pm, UK Regulatory (RNS & others)
tonsil: I suspect that abc are being fingered as the antibody test provider. That will detect those who have had it and recovered from it. Can't think of any other explanation.
erogenous jones: Not often a share price rises on Ex-Dividend date, but not complaining. Looks as if I was way off the mark in my last post. China is getting back to work, so I suspect that the UK will follow suit in June or thereabouts
apad: I have to be careful about confirmation bias as I have sold a lot of ABC. Revenue "11.6% in the first half on a reported basis and 9.1% on a constant currency basis," Removing China (growth of 17.4%) I calculate ROW growth of 9.4% This would be 7.4% on a constant currency basis. Gross margin constant - 'adjusted operating profit margin' lower end of 25% - 28%. Doesn't say what the adjustment is and doesn't consider the continuing capital expenditure or comment on profit. Two acquisitions are expected to contribute approximately £4m of incremental revenue in the current fiscal year (FY2020) and be neutral to adjusted earnings. ""We have recently set out ambitious plans to double the scale of our business and we are making good progress in investing in, and scaling up, the company." So, big ambitions and ex growth but spending money like water and not saying anything about profit. apad
erogenous jones: Don't stress. There are frequent staccato movements in the share price Sometimes down and at other times up. If you are worried about your holding, then this is probably not for you. The price has risen 28% during 2019.
sunningdale1: Following on from my previous Open Orphans (ORPH) post, Cathal Friel has delivered as promised with the all share merger with hVIVO (HVO). Seeing as HVO was trading at 30p at the start of the year, 2.47 ORPH shares for for each HVO share at 15.6p is great value. This follows partnerships with biopharma giant Ipsen Group and Venn’s deal with Carna Bioscience, and will leverage up and commercialise HVO’s sb through the Open Orphan health data platform. At 5.6p this still values ORPH at just £14m - combine in HVO at £11m plus the preferred partnership agreements and ORPH is set for a big 2020
buywell3: abc share price imo at bottom support line as i key dyor
mw8156: significant fall in the share price might result in it being taken over as the leading antibody company, their cash generative nature and their huge catalogue of 18000 validated antibodies and that would be Britain's only leading life sciences tools company disappearing which would be a shame after Illumina snapped up our sequencing technology.
erogenous jones: City did not like the figures. Sharp rises and sharp falls (in the share price) are normal for this company.
Abcam share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210307 18:58:08